Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Endotoxic lipopolysaccharide (LPS) with potent immunostimulatoryactivity is recognized by the receptor complex of MD-2 and Toll-likereceptor 4. Crystal structures of human MD-2 and its complexwith the antiendotoxic tetra-acylated lipid A core of LPS havebeen determined at 2.0 and 2.2 angstrom resolutions, respectively.MD-2 shows a deep hydrophobic cavity sandwiched by two ßsheets, in which four acyl chains of the ligand are fully confined.The phosphorylated glucosamine moieties are located at the entranceto the cavity. These structures suggest that MD-2 plays a principalrole in endotoxin recognition and provide a basis for antisepticdrug development.
1 Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. 2 Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan. 3 Division of Infectious Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. 4 CREST, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan.
* To whom correspondence should be addressed. E-mail: satowy{at}mol.f.u-tokyo.ac.jp
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Katherine A. Fitzgerald and Douglas T. Golenbock (15 June 2007) Science316 (5831), 1574.
[DOI: 10.1126/science.1144483] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Novel Roles of Lysines 122, 125, and 58 in Functional Differences between Human and Murine MD-2.
J. Vasl, A. Oblak, T. L. Gioannini, J. P. Weiss, and R. Jerala (2009)
J. Immunol.
183, 5138-5145
|Abstract »|Full Text »|PDF »
Cooperation between PU.1 and CAAT/Enhancer-binding Protein {beta} Is Necessary to Induce the Expression of the MD-2 Gene.
P. Tissieres, T. Araud, A. Ochoda, G. Drifte, I. Dunn-Siegrist, and J. Pugin (2009)
J. Biol. Chem.
284, 26261-26272
|Abstract »|Full Text »|PDF »
Lipopolysaccharide binding of the mite allergen Der f 2.
S. Ichikawa, T. Takai, T. Yashiki, S. Takahashi, K. Okumura, H. Ogawa, D. Kohda, and H. Hatanaka (2009)
Genes Cells
14, 1055-1065
|Abstract »|Full Text »|PDF »
Natural Phosphoryl and Acyl Variants of Lipid A from Neisseria meningitidis Strain 89I Differentially Induce Tumor Necrosis Factor-{alpha} in Human Monocytes.
C. M. John, M. Liu, and G. A. Jarvis (2009)
J. Biol. Chem.
284, 21515-21525
|Abstract »|Full Text »|PDF »
Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation.
M. Mancek-Keber, H. Gradisar, M. I. Pestana, G. M. de Tejada, and R. Jerala (2009)
J. Biol. Chem.
284, 19493-19500
|Abstract »|Full Text »|PDF »
Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria.
P. Gross, K. Brandl, C. Dierkes, J. Scholmerich, B. Salzberger, T. Gluck, and W. Falk (2009)
Infect. Immun.
77, 2925-2931
|Abstract »|Full Text »|PDF »
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer.
L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle (2009)
Pharmacol. Rev.
61, 177-197
|Abstract »|Full Text »|PDF »
Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin.
N. Resman, J. Vasl, A. Oblak, P. Pristovsek, T. L. Gioannini, J. P. Weiss, and R. Jerala (2009)
J. Biol. Chem.
284, 15052-15060
|Abstract »|Full Text »|PDF »
The roles of TLRs, RLRs and NLRs in pathogen recognition.
Discovery of new biosynthetic pathways: the lipid A story.
C. R. H. Raetz, Z. Guan, B. O. Ingram, D. A. Six, F. Song, X. Wang, and J. Zhao (2009)
J. Lipid Res.
50, S103-S108
|Abstract »|Full Text »|PDF »
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4.
T. Roger, C. Froidevaux, D. Le Roy, M. K. Reymond, A.-L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra (2009)
PNAS
106, 2348-2352
|Abstract »|Full Text »|PDF »
Purification and Characterization of the Lipid A 1-Phosphatase LpxE of Rhizobium leguminosarum.
M. J. Karbarz, D. A. Six, and C. R. H. Raetz (2009)
J. Biol. Chem.
284, 414-425
|Abstract »|Full Text »|PDF »
IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients.
O. Sandanger, L. Ryan, J. Bohnhorst, A.-C. Iversen, H. Husebye, O. Halaas, L. Landro, P. Aukrust, S. S. Froland, G. Elson, et al. (2009)
J. Immunol.
182, 588-595
|Abstract »|Full Text »|PDF »
Biophysical Characterization of Refolded Drosophila Spatzle, a Cystine Knot Protein, Reveals Distinct Properties of Three Isoforms.
A. Hoffmann, A. Funkner, P. Neumann, S. Juhnke, M. Walther, A. Schierhorn, U. Weininger, J. Balbach, G. Reuter, and M. T. Stubbs (2008)
J. Biol. Chem.
283, 32598-32609
|Abstract »|Full Text »|PDF »
A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.
T. Kiyokawa, S. Akashi-Takamura, T. Shibata, F. Matsumoto, C. Nishitani, Y. Kuroki, Y. Seto, and K. Miyake (2008)
Int. Immunol.
20, 1407-1415
|Abstract »|Full Text »|PDF »
Paclitaxel Binding to Human and Murine MD-2.
S. M. Zimmer, J. Liu, J. L. Clayton, D. S. Stephens, and J. P. Snyder (2008)
J. Biol. Chem.
283, 27916-27926
|Abstract »|Full Text »|PDF »
Unique Properties of the Chicken TLR4/MD-2 Complex: Selective Lipopolysaccharide Activation of the MyD88-Dependent Pathway.
Isolation of Monomeric and Dimeric Secreted MD-2: ENDOTOXIN{middle dot}sCD14 AND TOLL-LIKE RECEPTOR 4 ECTODOMAIN SELECTIVELY REACT WITH THE MONOMERIC FORM OF SECRETED MD-2.
A. Teghanemt, R. L. Widstrom, T. L. Gioannini, and J. P. Weiss (2008)
J. Biol. Chem.
283, 21881-21889
|Abstract »|Full Text »|PDF »
Elucidation of the MD-2/TLR4 Interface Required for Signaling by Lipid IVa.
C. Walsh, M. Gangloff, T. Monie, T. Smyth, B. Wei, T. J. McKinley, D. Maskell, N. Gay, and C. Bryant (2008)
J. Immunol.
181, 1245-1254
|Abstract »|Full Text »|PDF »
Functional Activity of MD-2 Polymorphic Variant Is Significantly Different in Soluble and TLR4-Bound Forms: Decreased Endotoxin Binding by G56R MD-2 and Its Rescue by TLR4 Ectodomain.
J. Vasl, P. Prohinar, T. L. Gioannini, J. P. Weiss, and R. Jerala (2008)
J. Immunol.
180, 6107-6115
|Abstract »|Full Text »|PDF »
Phagocytosis and intracellular killing of MD-2 opsonized Gram-negative bacteria depend on TLR4 signaling.
V. Jain, A. Halle, K. A. Halmen, E. Lien, M. Charrel-Dennis, S. Ram, D. T. Golenbock, and A. Visintin (2008)
Blood
111, 4637-4645
|Abstract »|Full Text »|PDF »
Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria.
P. Tissieres, I. Dunn-Siegrist, M. Schappi, G. Elson, R. Comte, V. Nobre, and J. Pugin (2008)
Blood
111, 2122-2131
|Abstract »|Full Text »|PDF »
The Differential Impact of Disulfide Bonds and N-Linked Glycosylation on the Stability and Function of CD14.
J. Meng, P. Parroche, D. T. Golenbock, and C. J. McKnight (2008)
J. Biol. Chem.
283, 3376-3384
|Abstract »|Full Text »|PDF »
Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?.
R. S. Munford (2008)
Infect. Immun.
76, 454-465
|Full Text »|PDF »
Novel Roles in Human MD-2 of Phenylalanines 121 and 126 and Tyrosine 131 in Activation of Toll-like Receptor 4 by Endotoxin.
A. Teghanemt, F. Re, P. Prohinar, R. Widstrom, T. L. Gioannini, and J. P. Weiss (2008)
J. Biol. Chem.
283, 1257-1266
|Abstract »|Full Text »|PDF »
Transfer of Monomeric Endotoxin from MD-2 to CD14: CHARACTERIZATION AND FUNCTIONAL CONSEQUENCES.
A. Teghanemt, P. Prohinar, T. L. Gioannini, and J. P. Weiss (2007)
J. Biol. Chem.
282, 36250-36256
|Abstract »|Full Text »|PDF »
